Literature DB >> 30518447

Evaluating Transfer of Modafinil Into Human Milk During Lactation: A Case Report.

Sanjay Aurora1, Nadia Aurora2, Palika Datta3, Kathleen Rewers-Felkins3, Teresa Baker4, Thomas W Hale3.   

Abstract

ABSTRACT: We present a case of a 27-year-old woman in whom idiopathic hypersomnolence was diagnosed in adolescence with adequate symptomatic control on daily dosage of 250 mg of modafinil. She maintained this dosage throughout her pregnancy and during the peripartum period, but did not breastfeed her newborn because of a lack of information on the transmission of modafinil in human breast milk. Samples of her breast milk were obtained at various times over a 24-hour period and analyzed using liquid chromatography mass spectrometry. The relative infant dose was calculated to be 5.3%, below the threshold of concern for drug passage via breast milk. This is the first reported case of modafinil transfer into human breast milk. Given the drug's use in a variety of sleep disorders, the results of this case can be used to advise breastfeeding mothers prescribed modafinil.
© 2018 American Academy of Sleep Medicine.

Entities:  

Keywords:  armodafinil; human breast milk; idiopathic hypersomnia; modafinil

Mesh:

Substances:

Year:  2018        PMID: 30518447      PMCID: PMC6287734          DOI: 10.5664/jcsm.7546

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  8 in total

Review 1.  International classification of sleep disorders-third edition: highlights and modifications.

Authors:  Michael J Sateia
Journal:  Chest       Date:  2014-11       Impact factor: 9.410

2.  Prospective evaluation of a model for the prediction of milk:plasma drug concentrations from physicochemical characteristics.

Authors:  E J Begg; H C Atkinson; S B Duffull
Journal:  Br J Clin Pharmacol       Date:  1992-05       Impact factor: 4.335

3.  Idiopathic hypersomnia: clinical features and response to treatment.

Authors:  Mohsin Ali; R Robert Auger; Nancy L Slocumb; Timothy I Morgenthaler
Journal:  J Clin Sleep Med       Date:  2009-12-15       Impact factor: 4.062

4.  Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications.

Authors:  Nora D Volkow; Joanna S Fowler; Jean Logan; David Alexoff; Wei Zhu; Frank Telang; Gene-Jack Wang; Millard Jayne; Jacob M Hooker; Christopher Wong; Barbara Hubbard; Pauline Carter; Donald Warner; Payton King; Colleen Shea; Youwen Xu; Lisa Muench; Karen Apelskog-Torres
Journal:  JAMA       Date:  2009-03-18       Impact factor: 56.272

Review 5.  Idiopathic hypersomnia.

Authors:  Michel Billiard; Karel Sonka
Journal:  Sleep Med Rev       Date:  2015-09-03       Impact factor: 11.609

6.  Narcolepsy and pregnancy: a retrospective European evaluation of 249 pregnancies.

Authors:  Eszter Maurovich-Horvat; David Kemlink; Birgit Högl; Birgit Frauscher; Laura Ehrmann; Peter Geisler; Katharina Ettenhuber; Geert Mayer; Rosa Peraita-Adrados; Elena Calvo; Gert Jan Lammers; Astrid Van der Heide; Luigi Ferini-Strambi; Giuseppe Plazzi; Francesca Poli; Yves Dauvilliers; Poul Jennum; Helle Leonthin; Johannes Mathis; Aleksandra Wierzbicka; Francisco J Puertas; Pierre A Beitinger; Isabelle Arnulf; Renata L Riha; Maria Tormášiová; Jana Slonková; Sona Nevšímalová; Karel Sonka
Journal:  J Sleep Res       Date:  2013-04-08       Impact factor: 3.981

7.  Modafinil in the treatment of idiopathic hypersomnia without long sleep time--a randomized, double-blind, placebo-controlled study.

Authors:  Geert Mayer; Heike Benes; Peter Young; Marion Bitterlich; Andrea Rodenbeck
Journal:  J Sleep Res       Date:  2014-09-05       Impact factor: 3.981

8.  Mechanisms of modafinil: A review of current research.

Authors:  Paul Gerrard; Robert Malcolm
Journal:  Neuropsychiatr Dis Treat       Date:  2007-06       Impact factor: 2.570

  8 in total
  1 in total

Review 1.  Sleep Pharmacotherapy for Common Sleep Disorders in Pregnancy and Lactation.

Authors:  Margaret A Miller; Niharika Mehta; Courtney Clark-Bilodeau; Ghada Bourjeily
Journal:  Chest       Date:  2019-10-14       Impact factor: 9.410

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.